Article ID Journal Published Year Pages File Type
5833046 International Immunopharmacology 2013 8 Pages PDF
Abstract
► ALR increases the survival time of the engraftments. ► ALR inhibits the inflammatory injury of the engraftments and liver. ► ALR suppresses the immunological rejections and protects the engraftments. ► ALR overcomes the main limitations of intraperitoneal HCT. ► Co-treatment with ALR and HCT improves the survival rate of ALF rats.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , ,